Abstract
Norepinephrine (NE) is involved in many cardiovascular diseases such as congestive heart failure. We have recently reported that NE had a comitogenic effect in isolated cardiac fibroblasts, and that it activated p42/p44 mitogen activated protein kinase (MAPK). This study was designed to characterize a possible mechanism involved in the proliferative effect of NE. Isolated rat cardiac fibroblasts were exposed to NE (10μM) for up to 8 h, and interleukin-6 (IL-6) expression was measured by Ribonuclease Protection Assay and Western blotting. The activity of p42/p44MAPK was analyzed by Western blotting. Cell number was assessed by use of a Coulter Counter. IL-6/GAPDH mRNA was increased by NE in a time-dependent manner reaching 23 fold stimulation after 1 h compared to untreated samples. Immunoreactivity to IL-6 was not found in controls. After 16h of exposure to NE, IL-6 protein was detected. It further increased up to 48 h. The effect of NE on IL-6 mRNA was abolished by the β-adrenoceptor blockers propranolol, metoprolol (β1) and ICI 118.551 (β2), but not by the α-adrenoceptor blockers prazosin (α1) and yohimbine (α2). The MAPK-inhibitor PD98059 suppressed the NE-induced MAPK activation in a concentration-dependent fashion after 5 min, attenuated the NE-induced IL-6 expression after 2 h, and suppressed the proliferative effect of NE from 53 to 18% after 48 h. Recombinant IL-6 caused an increase in proliferation by 31% after 48 h. Simultaneous application of the IL-6 antibody reduced the NE-induced proliferation to 34%, and completely prevented the IL-6 induced effect. These results suggest that NE induces proliferation of rat cardiac fibroblasts in part by increasing the expression of IL-6 through regulation of MAPK.
Similar content being viewed by others
References
Zierhut W, Zimmer H-G: Significance of myocardial alpha-and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65: 1417-1425, 1989
Leicht M, Greipel N, Zimmer H-G: Comitogenic effect of catocholamines on rat cardiac fibroblasts in culture. Cardiovasc Res 48: 274-284, 2000
Barth W, Deten A, Bauer M, Reinohs M, Leicht M, Zimmer H-G: Differential remodeling of the left and right heart after norepinephrine treatment in rats: Studies on cytokines and collagen. J Mol Cell Cardiol 32: 273-284, 2000
Bürger A, Benicke M, Deten A, Zimmer H-G: Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol Heart Circ Physiol 281: H14-H21, 2001
Sano M, Fukuda K, Kodama H, Takahashi T, Kato T, Hakuno D, Sato T, Manabe T, Tahara S, Ogawa S: Autocrine/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation. Biochem Biophys Res Commun 269: 798-802, 2000
Roth M, Nauck M, Tamm M, Perruchoud AP, Ziesche R, Block LH: Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells. Proc Natl Acad Sci USA 92: 1312-1316, 1995
Mihara M, Moriya Y, Kishimoto T, Ohsugi Y: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 34: 321-325, 1995
Miles SA, Rezai AR, Salazar-Gonzalez JF, Vander Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T et al.: AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87: 4068-4072, 1990
Strong SA, Pizarro TT, Klein JS, Cominelli F, Fiocchi C: Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells. Gastroenterology 114: 1244-1256, 1998
Hirota H, Yoshida K, Kishimoto T, Taga T: Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92: 4862-4866, 1995
Yamazaki T, Komuro I, Zou Y, Kudoh S, Shiojima I, Hiroi Y, Mizuno T, Aikawa R, Takano H, Yazaki Y: Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1-and beta-adrenoceptors. Circulation 95: 1260-1268, 1997
Thorburn J, McMahon M, Thorburn A: Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J Biol Chem 269: 30580-30586, 1994
Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH: Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res 78: 954-961, 1996
Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E: Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int 56: 1366-1377, 1999
Hayashi R, Yamashita N, Matsui S, Fujita T, Araya J, Sassa K, Arai N, Yoshida Y, Kashii T, Maruyama M, Sugiyama E, Kobayashi M: Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK-and p38 MAPK-dependent mechanisms. Eur Respir J 16: 452-458, 2000
Leicht M, Briest W, Hölzl A, Zimmer H-G: Serum depletion induces cell loss of rat cardiac fibroblasts and increased expression of extra-cellular matrix proteins in surviving cells. Cardiovasc Res 52: 429-437, 2001
Henkel AW, Bieger SC: Quantification of proteins dissolved in an electrophoresis sample buffer. Anal Biochem 223: 329-331, 1994
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
Briest W, Hölzl A, Rassler B, Deten A, Leicht M, Baba HA, Zimmer HG: Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc Res 52: 265-273, 2001
Murray DR, Prabhu SD, Chandrasekar B: Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101: 2338-2341, 2000
Prabhu SD, Chandrasekar B, Murray DR, Freeman GL: Beta-adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 101: 2103-2109, 2000
Steinberg SF: The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85: 1101-1111, 1999
Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91, 1997
Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001
Hafizi S, Chester AH, Yacoub MH: Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Clin Exp Pharmacol Physiol 26: 511-513, 1999
Carter AB, Monick MM, Hunninghake GW: Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20: 751-758, 1999
Tuyt LM, Dokter WH, Birkenkamp K, Koopmans SB, Lummen C, Kruijer W, Vellenga E: Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. J Immunol 162: 4893-4902, 1999
Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, Glembotski CC: p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 275: 23814-23824, 2000
Hirano T, Kishimoto T: Interleukin 6 and plasma cell neoplasias. Prog Growth Factor Res 1: 133-142, 1989
Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S: Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275: 29717-29723, 2000
Wegenka UM, Buschmann J, Lutticken C, Heinrich PC, Horn F: Acutephase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 13: 276-288, 1993
Zhong Z, Wen Z, Darnell Jr. JE: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98, 1994
Lutticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T et al.: Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263: 89-92, 1994
Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T: Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98: 346-352, 1998
Pan J, Fukuda K, Kodama H, Sano M, Takahashi T, Makino S, Kato T, Manabe T, Hori S, Ogawa S: Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels 13: 199-208, 1998
Xue H, McCauley RL, Zhang W, Martini DK: Altered interleukin-6 expression in fibroblasts from hypertrophic burn scars. J Burn Care Rehab 21: 142-146, 2000
Duncan MR, Berman B: Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 97: 686-692, 1991
Yue P, Massie BM, Simpson PC, Long CS: Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 275: H250-H258, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leicht, M., Briest, W. & Zimmer, HG. Regulation of norepinephrine-induced proliferation in cardiac fibroblasts by interleukin-6 and p42/p44 mitogen activated protein kinase. Mol Cell Biochem 243, 65–72 (2003). https://doi.org/10.1023/A:1021655023870
Issue Date:
DOI: https://doi.org/10.1023/A:1021655023870